SCHEMBL13870935

SCHEMBL13870935

COc1cccc(-c2ccc3cc(OC)c(OC)cc3n2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 3/20 0.61
PDGFRA P16234 2/20 0.61
SMN1; SMN2 Q16637 6/20 0.54
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 4/20 0.54
RAB9A P51151 3/20 0.54
NPC1 O15118 2/20 0.54
MAP4K4 O95819 1/20 0.52
DYRK1A Q13627 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50
TOP1 P11387 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
CYP19A1 P11511 1/20 0.48
MAPT P10636 2/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
GLA P06280 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870903 0.86 MAP4K4 (0.51) PDGFRBPDGFRASMN1; SMN2KDM4EALDH1A1
SCHEMBL16487821 0.86 PDGFRB (0.47) PDGFRBPDGFRASMN1; SMN2KDM4EALDH1A1
SCHEMBL3012991 0.86 MAP4K4 (0.57) PDGFRBPDGFRASMN1; SMN2KDM4EALDH1A1
SCHEMBL13399544 0.85 ADORA2A (0.52) PDGFRBPDGFRASMN1; SMN2KDM4EALDH1A1
SCHEMBL13870921 0.84 SMN1; SMN2 (0.54) PDGFRBPDGFRASMN1; SMN2KDM4EALDH1A1
SCHEMBL8501511 0.84 SMN1; SMN2 (0.57) PDGFRBPDGFRASMN1; SMN2KDM4EALDH1A1
SCHEMBL29501311 0.83 SMN1; SMN2 (0.66) PDGFRBPDGFRASMN1; SMN2KDM4EALDH1A1
SCHEMBL28596277 0.83 SMN1; SMN2 (0.66) PDGFRBPDGFRASMN1; SMN2KDM4EALDH1A1
SCHEMBL6851588 0.83 RAB9A (0.69) SMN1; SMN2KDM4EALDH1A1RAB9ANPC1
SCHEMBL29746123 0.83 RAB9A (0.69) SMN1; SMN2KDM4EALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 PDGFRB 1748/4885PDGFRA 1137/4885SMN1; SMN2 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.